India's Adani Enterprises reported a more than seven-fold surge in second-quarter profit on Tuesday, as higher demand in its renewable energy division overshadowed weakness in the mainstay coal trading segment.

Cipla Ltd reported a 15.2% year-on-year increase in consolidated net profit to ₹1,303.53 crore for Q2FY25, with revenue at ₹7,051.02 crore, a 10.5% rise. The North America segment grew 4% to $237 million,

Drug major Cipla on Tuesday reported a 17 per cent increase in consolidated net profit to Rs 1,303 crore for the second quarter ended September 2024, driven by robust sales across markets

Cipla , India's third-largest generic drugmaker by sales, reported a 15.2% rise in second-quarter profit that beat estimates, driven by higher sales of its respiratory and cancer drugs in its key India and North American markets.

The Mumbai-based firm’s consolidated revenue from operations rose to ₹7,051.02 crore in the September quarter, up from ₹6,678.15 crore a year ago.

Cipla posted a 15.2% rise/decline in its net profit for the second quarter of the financial year, though shares were still in the red on Tuesday. What Happened: India’s third-largest pharmaceutical company said its net profit attributable to owners came in at ₹1,

Indian consumer goods maker Marico reported second-quarter profit well above market estimates on Tuesday, propped up by price hikes undertaken to offset higher raw material prices.

Pharma major Cipla Ltd on Tuesday reported an 15.2% year-on-year rise in its consolidated net profit for the fiscal's second quarter ended September (Q2FY25) to ₹1,303.53 crore. The company had reported a profit of ₹1,

Cipla is set to report a 3-6% revenue growth for the September quarter, as forecasted by four brokerages. The earnings for Q2FY25 will be announced on October 29, 2024. Estimates for net profit also show a potential increase of 4-5.